A study conducted by Zhang et al. demonstrates through in-vitro functional investigations that the overexpression of miR-22-3p or the inhibition of MALAT-1 could significantly diminish the survival, growth, and drug resistance of gastric cancer cells while concurrently promoting cell death. The gene discussed is MALAT1; the disease is gastric cancer.